🏳️‍🌈 STI Risk in the LGBTQ+ Community — What Often Gets Overlooked

Sexual health information has a representation problem. Most public health messaging is written for a default audience — cisgender, heterosexual, navigating a relatively uncomplicated relationship to their own body and identity. For LGBTQ+ individuals, the result is a persistent set of gaps — risks that go unacknowledged, testing that doesn't cover the right sites, and guidance that simply doesn't reflect how queer people actually live.

This isn't just an inconvenience. It has real health consequences. Here's what those gaps actually look like — and what filling them requires.

The site-specific testing gap

This is the most consequential and least discussed gap in sexual health care for LGBTQ+ individuals — particularly gay and bisexual men.

Standard STI screens default to urine testing. A urine test detects urethral infections. It detects nothing else.

For anyone who engages in anal or oral sex, this is a critical gap. Chlamydia and gonorrhea can infect the throat and rectum independently — and infections at these sites are almost universally asymptomatic. A person can have active infections in both the throat and rectum, test negative on a urine-only screen, and walk away believing they're clear.

Research consistently shows that a significant proportion of chlamydia and gonorrhea infections in men who have sex with men are detected only through rectal and pharyngeal swabs — not urine. Without site-specific testing, these infections go undetected, untreated, and transmissible.

Comprehensive testing for gay and bisexual men and others who engage in anal or oral sex must include throat, rectal, and urethral swabs. Not as an optional addition — as the standard.

The "lesbian and bisexual women are low risk" myth

One of the most persistent and damaging myths in sexual health is that women who have sex with women face little or no STI risk. This myth is inaccurate — and the healthcare system's tendency to treat it as true has left lesbian and bisexual women consistently undertested and underserved.

Herpes (HSV-1 and HSV-2) is one of the most commonly transmitted STIs between women — spreading through skin-to-skin contact and transmissible even without visible sores through asymptomatic shedding.

HPV can be transmitted through genital contact, shared sex toys, and skin-to-skin contact between women. Certain high-risk HPV strains are associated with cervical cancer — making regular cervical screening as relevant for lesbian and bisexual women as for anyone else.

Bacterial Vaginosis (BV) is significantly more prevalent among women who have sex with women than in the general population and can be sexually transmitted between female partners.

Chlamydia, gonorrhea, syphilis, and trichomoniasis can all be transmitted through intimate contact between women.

The risk is real. The fact that healthcare providers frequently don't ask about the gender of patients' partners — or assume heterosexuality by default — means it consistently goes unaddressed.

Trans and non-binary individuals — the exclusion from guidelines

Sexual health guidelines are written almost exclusively around cisgender bodies and heterosexual relationships. Trans and non-binary individuals frequently find that standard health advice doesn't map onto their situation — leaving them without relevant guidance on what testing is appropriate, what risks apply, and how to access care that reflects who they are.

The key principle — which standard guidelines rarely articulate clearly — is that anatomy, not gender identity, determines which STI tests are relevant and which transmission routes apply. A trans woman who has not had gender-affirming surgery has different testing needs than one who has. A non-binary person's relevant screenings depend on their specific anatomy, their partners' anatomy, and their sexual practices.

Standard intake forms and screening checklists — which default to gender as a proxy for anatomy — frequently miss what trans and non-binary individuals actually need. Providers who ask about anatomy rather than assuming from identity provide meaningfully better care.

HIV risk — the ongoing disparity

HIV remains disproportionately prevalent among gay and bisexual men in most countries — a disparity that persists despite decades of prevention work and the availability of highly effective tools.

The disparity is not inevitable. It reflects the interaction of elevated biological transmission risk through anal sex, network effects within communities, and — critically — inconsistent uptake of the prevention tools that would close the gap.

PrEP reduces the risk of HIV from sex by approximately 99% when taken consistently. In many countries, uptake among eligible gay and bisexual men remains significantly below what it would need to be to substantially reduce transmission at the community level.

Knowing about PrEP is not the same as being on it. Being on it intermittently is not the same as taking it consistently. And consistent PrEP use needs to be combined with regular STI testing — every three months — because PrEP covers HIV and nothing else.

The mpox dimension

Since the 2022 global mpox outbreak, mpox has become part of the sexual health conversation for gay and bisexual men and others in higher-risk networks. Mpox spreads through skin-to-skin contact and can affect areas not covered by condoms — making transmission possible even with barrier use.

The JYNNEOS vaccine is effective against mpox and is available in many countries through sexual health clinics. If you're in a higher-risk group and haven't been vaccinated — or haven't completed the two-dose course — this is worth acting on.

Minority stress and its health consequences

Understanding STI risk in the LGBTQ+ community requires acknowledging one factor that mainstream sexual health guidance almost never addresses — minority stress.

The chronic stress that comes from navigating stigma, discrimination, and systems that weren't designed with LGBTQ+ lives in mind has documented effects on immune function, on sexual decision-making, and on engagement with healthcare. Elevated minority stress is associated with lower rates of testing, less consistent protective behaviour, and reduced engagement with care — all of which directly affect STI risk.

This doesn't mean LGBTQ+ individuals are less capable of taking care of their health. It means the systems around them create specific additional friction — and that removing that friction is part of what effective sexual health care for this community requires.

Where CLEAR fits in

CLEAR's at-home Ship Kit was designed with the specific gaps in standard care for LGBTQ+ individuals in mind.

Urine, oral, and rectal sample collection — covering all three sites where STIs can infect independently. HIV, chlamydia, gonorrhea, syphilis, and hepatitis B and C — comprehensive coverage in a single kit. PCR-based laboratory analysis — the most sensitive method available. Results delivered privately to a personal CLEAR account within 48 hours.

No waiting room. No intake form that doesn't fit. No provider who might make assumptions. No system that wasn't built for you. 🏳️‍🌈🤍

🔗 Learn more via the link in Bio.

Bottom line

The STI risks that LGBTQ+ individuals face are specific, documented, and frequently overlooked by systems that weren't designed with queer lives in mind. Site-specific testing. Accurate risk information for lesbian and bisexual women. Anatomy-based care for trans and non-binary people. Consistent HIV prevention. These aren't niche concerns — they're the baseline of competent sexual health care for this community.

Knowing the gaps exist is the first step to closing them. 🤍

The information in this article is intended for general educational purposes only and does not constitute medical advice. Please consult a qualified healthcare professional for personal medical guidance.